Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Citations number
33
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
We studied the prognostic value of clinical and laboratory variables, measu
red before blood cell transplantation, in predicting complete response amon
g patients undergoing autologous blood cell transplantation for relapsed or
primary refractory myeloma, Sixty-seven patients who underwent transplanta
tion for relapsed or primary refractory myeloma were studied. The overall r
esponse rate was 90%, and the complete response rate was 33%, Low beta(2)-m
icroglobulin (less than or equal to 2.7 mg/l) was associated with a signifi
cantly better complete response rate compared with high levels (54 vs 19%,
P = 0.002). Similarly, the complete response rate was 39% when the bone mar
row plasma cell percentage was low (<40%) and 21% with greater involvement
(P = 0.04), Complete response rate was 50% when beta(2)-microglobulin and b
one marrow plasma cell percentage were low, 36% if either was high, and 12%
when both were high (P = 0.01). Median survival measured from initial diag
nosis of myeloma was 51 months. Overall survival after transplantation was
better among responders who achieved complete response than those who did n
ot: median survival, 24 vs 11 months, P = 0.04 (log-rank) and 0.009 (Gehan-
Wilcoxon). Attainment of a complete response independently predicted better
survival in a multivariate analysis. beta(2)-Microglobulin and bone marrow
plasma cell percentage predict complete responders among patients undergoi
ng transplantation for myeloma.